Fate Therapeutics Inc. (FATE) climbed 6.26% or 0.41 to $6.96. It is nearly 375489 shares traded, which is 54.42% compare to the average total volume 689953. The market cap of FATE is $290.13 million. The year to date change is 3.97%. The 52 week price range is from $2.52 to $7.25. Price of FATE have changed -0.15% during last week. It have changed 50.23% over last month, 61.33% over last 3 months, 115.46% over last 6 months and 118.33% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for FATE is 4.99. It is -28.30% below current price. The 200-day Moving Averages for FATE is 4.04. It is -41.95% below current price. The 52-week High is 7.25. It is 4.17% from the current price. The 52-week Low is 2.52. It is -63.79% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of FATE is 1.54 on 2017-12-29. Short % to float is 2.74%. There are some statistics of FATE. It is has market cap $290.13 million. The share outstanding is 41.69 million. The average volume is 689953. The percent of top 15 Institution holding is 63.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of FATE is -106.29%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of FATE is -61.85%.